Related Experiment Videos
Estimation of left ventricular function in patients with a left ventricular assist device
W A Mandarino1, J Gorcsan, T A Gasior
1Division of Cardiothoracic Surgery, University of Pittsburgh, Medical Center, Pennsylvania, USA.
Summary
A new method estimates left ventricular (LV) function recovery in patients with LVAD support. This technique, measuring end-systolic elastance (Ees), shows potential for clinical use in assessing LV performance.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Profound left ventricular (LV) dysfunction often requires left ventricular assist device (LVAD) support.
- Assessing LV function recovery in patients with LVADs is challenging with current methods.
- Early identification of LV recovery is crucial for optimizing patient management and device weaning.
Purpose of the Study:
- To introduce and evaluate a novel method for estimating LV end-systolic elastance (Ees) in patients supported by LVAD.
- To assess the feasibility of using transesophageal echocardiography and femoral arterial pressure to derive Ees.
- To determine if Ees can serve as a reliable indicator of LV functional recovery.
Main Methods:
- Simultaneous measurements of LV cross-sectional area (via transesophageal echocardiography) and femoral arterial pressure were recorded in 6 LVAD patients.
- LV area and pressure data were used to generate pressure-volume loops during brief LVAD off periods.
- End-systolic elastance (Ees) was estimated as the slope of the linear regression of end-systolic points on the pressure-area loops.
Main Results:
- The novel method successfully estimated Ees in LVAD patients.
- The average Ees in LVAD patients was 3.8 +/- 3.1 mmHg/cm², significantly lower than in 13 control patients (22.3 +/- 15.4 mmHg/cm²).
- This indicates impaired LV contractility in LVAD patients compared to controls.
Conclusions:
- The developed method provides a clinically feasible approach to estimate Ees in LVAD patients.
- This technique may be valuable for monitoring and assessing left ventricular recovery during LVAD therapy.
- Further studies are warranted to validate Ees as a biomarker for LVAD patient management.